Core Viewpoint - The article highlights the advancements and innovations in the optical endoscope products developed by Zhuowai Medical, emphasizing their unique anti-fog technology and the supportive ecosystem in Wuhan for biomedicine companies [1][3][6]. Group 1: Company Innovations - Zhuowai Medical has developed optical endoscope products that are locally produced in Wuhan, addressing the common issue of fogging during surgeries with their patented thermal equilibrium technology, which ensures the endoscope remains fog-free throughout the procedure [1]. - The company has established a high-end medical imaging R&D and production base in Wuhan, which began operations in July 2023, overcoming technical barriers in imaging, lighting, and lens manufacturing [1][5]. Group 2: Industry Collaboration - The biomedicine innovation product application docking conference showcased various companies, including Zhuowai Medical and others, demonstrating the technological strength of Wuhan's biomedicine sector in the endoscope niche [2]. - The conference facilitated collaboration between innovative companies and medical institutions, promoting the integration of clinical needs with technological advancements [6]. Group 3: Government Support - The Wuhan government is actively supporting local biomedicine companies with financial incentives, offering up to 1 million yuan for equipment upgrades and 500,000 yuan for joint innovation projects between hospitals and enterprises [3][5]. - A draft policy aimed at supporting the innovation development of the biomedicine industry has been released, focusing on collaborative innovation and product development [5]. Group 4: Market Growth - The biomedicine industry in Wuhan is projected to exceed 500 billion yuan in total scale by 2024, reflecting a growth rate of 15.3%, positioning it as the leading region in central China [5].